Abstract | PURPOSE: METHOD: This hypothesis will need to be tested in a randomized controlled trial (RCT). The aim of the present pilot study is to obtain preliminary data to inform the design of a future RCT. Eight patients received a single injection of 500 units of BtxA ( Dysport((R)) Ipsen, Ltd) into the biceps brachii of the paretic arm. The patients' balance and mobility were assessed before and 2, 4 and 6 weeks after treatment using observational gait analysis and other subjective assessment scales. RESULTS: There was a significant reduction of the ARs after treatment but this did not appear to improve the patients' balance or mobility as assessed by the clinicians. Interestingly, seven out of the eight patients reported improvement in their walking. CONCLUSION: The discrepancy between the observed and reported effects of treatment could be due to the poor sensitivity of the outcome measures used in this study.
|
Authors | A M O Bakheit, J Sawyer |
Journal | Disability and rehabilitation
(Disabil Rehabil)
Vol. 24
Issue 10
Pg. 519-22
(Jul 10 2002)
ISSN: 0963-8288 [Print] England |
PMID | 12171641
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Anti-Dyskinesia Agents
- Botulinum Toxins
|
Topics |
- Adult
- Aged
- Anti-Dyskinesia Agents
(therapeutic use)
- Botulinum Toxins
(therapeutic use)
- Female
- Gait
(drug effects)
- Hemiplegia
(drug therapy)
- Humans
- Male
- Middle Aged
- Muscle Spasticity
(drug therapy)
- Pilot Projects
- Postural Balance
(drug effects)
- Prospective Studies
|